Description
GFAP may also be useful in differentiating gliomas from metastatic lesions in the brain. Neuroblastomas, Schwannomas, as well as extra-CNS tumors are not labeled. Negative staining has been observed with lymphatic tissue, muscle, gastrointestinal tract, liver, kidney, pancreas and bladder. Use of a monoclonal antibody typically will increase specificity and eliminate lot-to-lot variation seen with polyclonals.
Specifications
| WEIGHT | N/A |
|---|---|
| DIMENSIONS | N/A |
| INTENDED USE | RUO |
| SPECIES REACTIVITY | Human, Mouse, Rat |
| SOURCE | Mouse Monoclonal |
| CLONE | GA-5 |
| ISOTYPE | IgG1 |
| ANTIGEN | Glial Fibrillary Acidic Protein |
| LOCALIZATION | Cytoplasmic |
| POSITIVE CONTROL | Normal brain or astrocytoma |
